74 related articles for article (PubMed ID: 16170831)
1. In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model.
Izumi M; Kawakami Y; Glasgow JN; Belousova N; Everts M; Kim-Park S; Yamamoto S; Wang M; Le LP; Reynolds PN; Curiel DT
J Gene Med; 2005 Dec; 7(12):1517-25. PubMed ID: 16170831
[TBL] [Abstract][Full Text] [Related]
2. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus.
Hangalapura BN; Oosterhoff D; Aggarwal S; Wijnands PG; van de Ven R; Santegoets SJ; van den Tol MP; Hooijberg E; Pereboev A; van den Eertwegh AJ; Curiel DT; Scheper RJ; de Gruijl TD
J Immunother; 2010 Sep; 33(7):706-15. PubMed ID: 20664356
[TBL] [Abstract][Full Text] [Related]
3. A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system.
Korokhov N; Noureddini SC; Curiel DT; Santegoets SJ; Scheper RJ; de Gruijl TD
Mol Pharm; 2005; 2(3):218-23. PubMed ID: 15934782
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells.
Pereboev AV; Asiedu CK; Kawakami Y; Dong SS; Blackwell JL; Kashentseva EA; Triozzi PL; Aldrich WA; Curiel DT; Thomas JM; Dmitriev IP
Gene Ther; 2002 Sep; 9(17):1189-93. PubMed ID: 12170383
[TBL] [Abstract][Full Text] [Related]
5. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses.
Hakkarainen T; Hemminki A; Pereboev AV; Barker SD; Asiedu CK; Strong TV; Kanerva A; Wahlfors J; Curiel DT
Clin Cancer Res; 2003 Feb; 9(2):619-24. PubMed ID: 12576427
[TBL] [Abstract][Full Text] [Related]
6. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.
Tillman BW; de Gruijl TD; Luykx-de Bakker SA; Scheper RJ; Pinedo HM; Curiel TJ; Gerritsen WR; Curiel DT
J Immunol; 1999 Jun; 162(11):6378-83. PubMed ID: 10352250
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors.
Everts M; Kim-Park SA; Preuss MA; Passineau MJ; Glasgow JN; Pereboev AV; Mahasreshti PJ; Grizzle WE; Reynolds PN; Curiel DT
Gene Ther; 2005 Jul; 12(13):1042-8. PubMed ID: 15789059
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer.
Oshikiri T; Miyamoto M; Hiraoka K; Shichinohe T; Kawarada Y; Kato K; Suzuoki M; Nakakubo Y; Kondo S; Dosaka-Akita H; Kasahara N; Katoh H
Cancer Gene Ther; 2006 Sep; 13(9):856-63. PubMed ID: 16710347
[TBL] [Abstract][Full Text] [Related]
10. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
13. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
[TBL] [Abstract][Full Text] [Related]
14. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.
Nicklin SA; Von Seggern DJ; Work LM; Pek DC; Dominiczak AF; Nemerow GR; Baker AH
Mol Ther; 2001 Dec; 4(6):534-42. PubMed ID: 11735337
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
[TBL] [Abstract][Full Text] [Related]
16. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.
Dzojic H; Loskog A; Tötterman TH; Essand M
Prostate; 2006 Jun; 66(8):831-8. PubMed ID: 16491482
[TBL] [Abstract][Full Text] [Related]
19. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.
Tuettenberg A; Fondel S; Steinbrink K; Enk AH; Jonuleit H
Exp Dermatol; 2010 Jan; 19(1):44-53. PubMed ID: 19889024
[TBL] [Abstract][Full Text] [Related]
20. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Kikuchi T; Miyazawa N; Moore MA; Crystal RG
Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
